Table 2 Clinical characteristics of the populations with liver tissues enrolled in the study
From: IFI16 is involved in HBV-associated acute-on-chronic liver failure inflammation
group | NC | CHB | HBV-ACLF |
|---|---|---|---|
case | 19 | 59 | 17 |
sex(M/F) | ND | 46/13 | 16/1 |
age(years) | ND | 37(23-65) | 41(29-61) |
ALT(U/L) | ND | 50(7-570) | 40(11-156) |
AST(U/L) | ND | 37(15-256) | 92(40-202) |
Tbil(umol/L) | ND | 12.1(2.6-119.9) | 600.6(238-809) |
INR | ND | 1.03(0.87-1.35) | 2.88(2.11-5.83) |
PTA(%) | ND | 95(63-128) | 21(11-35) |
Log10 (HBV DNA) | ND | 5.42(0-8.54) | 2(0.83-8.05) |
HBsAg-positive | ND | 59 | 17 |
HBsAb-positive | ND | 0 | 0 |
HBeAg-positive | ND | 24 | 2 |
HBeAb-positive | ND | 35 | 15 |
HBcA-bpositive | ND | 59 | 17 |
MELD score | ND | ND | 33.33±2.02 |